作者
Stephen M Stribbling, Frank Friedlos, Janet Martin, Lawrence Davies, Robert A Spooner, Richard Marais, Caroline J Springer
发表日期
2000/1/20
期刊
Human gene therapy
卷号
11
期号
2
页码范围
285-292
出版商
Mary Ann Liebert, Inc.
简介
The role of the bystander effect in the treatment of a human breast carcinoma xenograft was studied by suicide gene therapy with carboxypeptidase G2 (CPG2) and CMDA. Cells expressing enzymatically active surface-tethered bacterial CPG2[stCPG2(Q)3] were mixed with control beta-galactosidase (beta-Gal)-expressing cells to give stCPG2(Q)3: beta-Gal ratios of, respectively: group 1, 0:100; group 2, 10:90; group 3, 50:50; and group 4, 100:0. Four days after injection of the cells into nude mice, the prodrug 4-[(2-chloroethyl)(2-mesyloxyethyl)amino]benzoyl-L-glutamic acid (CMDA) was administered. Tumor growth delay correlated well with the levels of stCPG2(Q)3 expression: group 1, 0 day delay; group 2, 10 days; group 3, 16 days; and group 4, 90 days. Similarly, the number of cures was strongly correlated to the levels of stCPG2(Q)3 activity: group 1, zero of six cured; group 2, one of six …
引用总数
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022141066952832221245211